Dow Up 0.35% Nasdaq Down 0.02%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.77 0.05(0.86%) Aug 20, 4:00PM EDT
Prev Close:5.82
Open:5.81
Bid:5.65 x 500
Ask:5.90 x 3000
1y Target Est:9.75
Beta:1.78
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.66 - 5.90
52wk Range:4.60 - 7.82
Volume:2,437,639
Avg Vol (3m):3,459,790
Market Cap:707.02M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 0.86%707.02M
ABT63.37B
GSK114.84B
RHHBY247.66B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):208.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback